[18F]FDG PET/CT in the staging of inflammatory breast cancer: A systematic review

Uden, Dominique J. P. van; Prins, M; Siesling, Sabine; Wilt, Johannes H. W. de; Blanken-Peeters, C.F.J.M.; Aarntzen, Erik H.J.G.

doi:10.1016/j.critrevonc.2020.102943

Cited by 15 publications

(7 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It also has increased radiation exposure compared to chest X-ray and chest CT that are commonly employed in the diagnostic work-up of these patients. Additionally, it has high-risk of spreading the disease in the nuclear medicine units and placing the staff and other patients who have been in contact with the patient at risk 19 , 20 , 21 .…”

Section: Discussionmentioning

confidence: 99%

Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies

Rafiee

Keshavarz

Katal

et al. 2021

Seminars in Nuclear Medicine

View full text Add to dashboard Cite

Purpose There have been several reports of the incidental detection of SARS-CoV-2 pneumonia on Positron Emission Tomography/Computed Tomography (PET/CT) studies, which represent the potential role of molecular imaging in detection and management of coronavirus disease 2019 (COVID-19). Here, we systematically review the value of PET/CT in this setting. Materials and Methods We conducted a systematic search on June 23, 2020, for PET studies with findings suggestive of COVID-19. Web of Science, PubMed, Scopus, EMBASE, and Google Scholar databases were used. Patients with at least one PET/CT imaging evaluation were included in the study. Results Fifty-two patients in 30 publications with a mean age of 60 ± 12.74 (age range; 27-87) were included in this study, of which 28(53.8%) were male, and 19(36.5%) were female. PET/CT was performed with 18 F-FDG for 49(94.2%), 18 F-choline for 2(3.8%), and 68 Ga-PSMA for 1 (1.9%) patients. The mean SUV max of pulmonary lesions with 18 F-FDG uptake was 4.9 ± 2.3. Moreover, 39(75%) cases had an underlying malignancy, including 18 different type of primary cancers and 6(11.5%) patients with metastatic disease. The most common pulmonary findings in PET/CT were bilateral hypermetabolic GGOs 39(75%), consolidation 18(34.6%), and interlobular thickening 4(7.6%). In addition, mediastinal 14(27%) and hilar 10(19.2%) lymph node involvement with increased metabolic activity were frequently identified. Conclusion Early diagnosis of SARS-CoV-2 pneumonia is not only crucial for both appropriate patient management but also helps to ensure appropriate post-exposure precautions are implemented for the department and hospital staff and those who have been in contact with the patient.

show abstract

Section: Discussionmentioning

confidence: 99%

Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies

Rafiee

Keshavarz

Katal

et al. 2021

Seminars in Nuclear Medicine

View full text Add to dashboard Cite

show abstract

“…1, 2). A recent systematic review showed that FDG-PET/CT outperforms conventional imaging procedures for the detection of locoregional and distant metastases in the diagnostic workup of inflammatory breast cancer patients [39]. The definition of locally advanced breast cancer varies somewhat in the literature.…”

Section: Initial Workup and Assessment Of N And M Status In The Tnm-ajcc "Anatomic" Classificationmentioning

confidence: 99%

Breast cancer: initial workup and staging with FDG PET/CT

Groheux

Hindié

2021

Clin Transl Imaging

View full text Add to dashboard Cite

Purpose Precise staging is needed to plan optimal management in breast cancer. 18F-fluorodeoxyglucose positron emission tomography coupled with computed tomography (FDG-PET/CT) offers high sensitivity in detecting extra axillary lymph nodes and distant metastases. This review aims to clarify in which groups of patients staging with FDG-PET/CT would be beneficial and should be offered. We also discuss how tumor biology and breast cancer subtypes should be taken into account when interpreting FDG-PET/CT scans. Methods We performed a comprehensive literature review and rigorous appraisal of research studies assessing indications for FDG-PET/CT in breast cancer. This assessment regarding breast cancer served as a basis for the recommendations set by a working group of the French Society of Nuclear Medicine, in collaboration with oncological societies, for developing good clinical practice recommendations on the use of FDG-PET/CT in oncology. Results FDG-PET/CT is useful for initial staging of breast cancer, independently of tumor phenotype (triple negative, luminal or HER2 +) and regardless of tumor grade. Considering histological subtype, FDG-PET/CT performs better for staging invasive ductal carcinoma, although it is also helpful for staging invasive lobular carcinomas. Based on the available data, FDG-PET/CT becomes useful for staging starting from clinical stage IIB. FDG-PET/CT is possibly useful in patients with clinical stage IIA (T1N1 or T2N0), but there is not enough strong data to recommend routine use in this subgroup. For clinical stage I (T1N0) patients, staging with FDG-PET/CT offers no added value. Conclusion FDG-PET/CT is useful for staging patients with breast cancer, starting from clinical stage IIB.

show abstract

“…Surgical resection can only be performed in patients without diffuse invasion or metastasis (Marconato et al, 2009;Raposo et al, 2017). 18 F-FDG PET/CT has been used to evaluate metastasis and determine the extent of pathologic involvement in humans with inflammatory breast cancer (Al-Faham et al, 2015;Baslaim et al, 2003;van Uden et al, 2020).…”

Section: Discussionmentioning

confidence: 99%

Evaluation of a dog with inflammatory mammary carcinoma using ¹⁸F‐2‐deoxy‐2‐fluoro‐d‐glucose positron emission tomography/computed tomography

Koo

Yun

Chae

et al. 2022

Veterinary Medicine & Sci

View full text Add to dashboard Cite

Inflammatory mammary carcinoma is known to be aggressive, which makes thorough evaluation of the severity of tumour infiltration and metastasis important in determining a recommended treatment course. This case report describes the use of 18F‐2‐deoxy‐2‐fluoro‐d‐glucose positron emission tomography/computed tomography for evaluating the invasiveness and metastasis of inflammatory mammary carcinoma in a dog.

show abstract

[18F]FDG PET/CT in the staging of inflammatory breast cancer: A systematic review

Cited by 15 publications

References 30 publications

Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies

Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies

Breast cancer: initial workup and staging with FDG PET/CT

Evaluation of a dog with inflammatory mammary carcinoma using ¹⁸F‐2‐deoxy‐2‐fluoro‐d‐glucose positron emission tomography/computed tomography

Contact Info

Product

Resources

About

[18F]FDG PET/CT in the staging of inflammatory breast cancer: A systematic review

Cited by 15 publications

References 30 publications

Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies

Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies

Breast cancer: initial workup and staging with FDG PET/CT

Evaluation of a dog with inflammatory mammary carcinoma using 18F‐2‐deoxy‐2‐fluoro‐d‐glucose positron emission tomography/computed tomography

Contact Info

Product

Resources

About

Evaluation of a dog with inflammatory mammary carcinoma using ¹⁸F‐2‐deoxy‐2‐fluoro‐d‐glucose positron emission tomography/computed tomography